Two recent studies have explored the effectiveness of quaternary ammonium compounds (QACs) in combating methicillin-resistant Staphylococcus aureus (MRSA). The first study conducted by researchers at the University of California, Davis, found that QACs were able to effectively kill MRSA strains in both planktonic and biofilm forms. The researchers utilized a combination of in vitro experiments and animal models to demonstrate the efficacy of QACs in eradicating MRSA infections. The second study, conducted by scientists at the University of Michigan, focused on the mechanism of action of QACs against MRSA. They discovered that QACs disrupt the bacterial cell membrane, leading to cell death. These findings have significant implications for the development of new antimicrobial agents to combat MRSA infections, particularly in healthcare settings where antibiotic resistance is a growing concern.